<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02504697</url>
  </required_header>
  <id_info>
    <org_study_id>H-32479</org_study_id>
    <nct_id>NCT02504697</nct_id>
  </id_info>
  <brief_title>DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer</brief_title>
  <acronym>DECAMP-2</acronym>
  <official_title>Detection of Early Lung Cancer Among Military Personnel Study 2 (DECAMP-2): Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American College of Radiology Imaging Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this project is to improve lung cancer screening in high-risk individuals by&#xD;
      identifying biomarkers of preclinical disease and disease risk that are measured in minimally&#xD;
      invasive and non-invasive biospecimens. Existing biomarkers for lung cancer diagnosis as well&#xD;
      as new biomarkers discovered specifically in this clinical setting will be examined.&#xD;
      Biomarkers that identify individuals at highest risk for being diagnosed with lung cancer&#xD;
      prior to the appearance of concerning symptoms could increase the utility of lung cancer&#xD;
      surveillance and the efficiency of lung cancer chemoprevention clinical trials. Achieving&#xD;
      these goals would improve the detection and treatment of early stage and incipient lung&#xD;
      cancer, while restricting the risk of these procedures to those individuals who currently&#xD;
      exhibit the early molecular warning signs of impending disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Detection of Early lung Cancer Among Military Personnel (DECAMP) consortium is a&#xD;
      multidisciplinary and translational research program that includes 7 Veterans Administration&#xD;
      Hospitals (VAH), the 4 designated Military Treatment Facilities (MTF) and 4 academic&#xD;
      hospitals as clinical study sites, several molecular biomarker laboratories, along with&#xD;
      Biostatics, Bioinformatics, Pathology and Biorepository cores. The DECAMP Coordinating Center&#xD;
      will facilitate rapid selection, design and execution of clinical studies within this&#xD;
      multi-institutional consortium. The ACRIN 4704 study will recruit one cohort to achieve the&#xD;
      aims of this study: a longitudinal screening cohort.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2011</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung Cancer</measure>
    <time_frame>Four years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Longitudinal Cohort</arm_group_label>
    <description>For this longitudinal screening cohort, we will enroll 800 participants who currently or historically smoked and who have a 10 year Bach risk model of lung cancer &gt; 2.5% (5). We will include participants 50 to 79 years old, with ≥10 cigarettes/day for current smokers, or ≥20 pack years for former smoker who quit 20 years ago or less. In order to further enrich for lung cancer risk, participants also will have COPD/emphysema or at least one first-degree relative with a diagnosis of lung cancer. We will exclude patients previously diagnosed with lung cancer. These patients will be followed for a total of 4 years with annual follow-up visits. Biosamples from airway and blood and images will be collected.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biosamples from airway and blood</intervention_name>
    <description>Identify biomarkers in biosamples from airway and blood for the preclinical detection of lung cancer.</description>
    <arm_group_label>Longitudinal Cohort</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, Urine, Sputum, Nasal brushing, Buccal scraping, Bronchial Biopsy, Bronchial brushing,&#xD;
      lung tissue&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Military personnel&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for longitudinal screening cohort&#xD;
&#xD;
          -  Ages 50 to 79 years;&#xD;
&#xD;
          -  Smoking status: Current or former smoker (≥10 cigarettes/day for current smokers, or&#xD;
             ≥20 pack years for former smoker who quit 20 years ago or less)&#xD;
&#xD;
          -  History of Chronic Obstructive Pulmonary Disease (COPD), emphysema, or at least one&#xD;
             first-degree relative with a diagnosis of lung cancer;&#xD;
&#xD;
          -  Willing to undergo fiberoptic bronchoscopy;&#xD;
&#xD;
          -  Able to tolerate all biospecimen collection as required by protocol;&#xD;
&#xD;
          -  Able to comply with standard-of-care follow-up visits, including clinical exams,&#xD;
             diagnostic work-ups, and imaging for a maximum of four years or until diagnosis of&#xD;
             lung cancer;&#xD;
&#xD;
          -  Able to fill out Patient Lung History questionnaire;&#xD;
&#xD;
          -  Willing and able to provide a written informed consent.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Diagnosis of lung cancer prior to the current assessment (that is, patients are&#xD;
             eligible if first lung cancer diagnosis has been recently confirmed by bronchoscopic&#xD;
             biopsy and is leading to resection surgery, but not if this is not a first diagnosis);&#xD;
&#xD;
          -  Contraindications to nasal brushing or fiberoptic bronchoscopy, including: ulcerative&#xD;
             nasal disease, hemodynamic instability, severe obstructive airway disease (i.e.,&#xD;
             disease severity does not allow for bronchoscopic procedures), unstable cardiac or&#xD;
             pulmonary disease, as well as other comorbidities leading to inability to protect&#xD;
             airway, or altered level of consciousness;&#xD;
&#xD;
          -  Allergies to any local anesthetic that may be used to obtain biosamples in the study;&#xD;
&#xD;
          -  Weight greater than that allowable by the CT scanner.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ehab Billatos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Denise Aberle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ehab Billatos, MD</last_name>
    <phone>617-358-7039</phone>
    <email>ebillato@bu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Perez, PhD</last_name>
    <phone>617-358-7253</phone>
    <email>perezmt@bu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Regents of the University of California LA (Los Angeles VA Healthcare System)</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Dubinett, MD</last_name>
      <email>SDubinett@mednet.ucla.edu</email>
    </contact>
    <contact_backup>
      <last_name>Gina Lee</last_name>
      <email>Gina.Lee@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Dubinett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gina Lee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steve Dubinett, MD</last_name>
      <email>SDubinett@mednet.ucla.edu</email>
    </contact>
    <contact_backup>
      <last_name>Babak Aryanfar</last_name>
      <email>Babak.Aryanfar@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Steve Dubinett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John S Parrish, MD</last_name>
      <email>john.parrish@med.navy.mil</email>
    </contact>
    <contact_backup>
      <last_name>Lindsey White</last_name>
      <email>lwhite@acr.org</email>
    </contact_backup>
    <investigator>
      <last_name>John S Parrish, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Denver Research Institute</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Keith, MD</last_name>
      <email>Robert.Keith@ucdenver.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mary Jackson</last_name>
      <email>mary.k.jackson@ucdenver.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Keith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Browning, MD</last_name>
      <email>robert.browningjr@med.navy.mil</email>
    </contact>
    <contact_backup>
      <last_name>Luis Rojas</last_name>
      <email>lrojas@hjfresearch.org</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Browning, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston University Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ehab Billatos, MD</last_name>
      <email>ehab.billatos@bmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Denise Fine</last_name>
      <email>Denise.Fine@bmc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Ehab Billatos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston VA Research Institute, Inc</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Goldstein, MD</last_name>
      <email>Ronald.Goldstein@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Kathleen LaCerda</last_name>
      <email>kathleen.lacerda@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Ronald Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Research Inc. Roswell Park Division</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Reid, PhD</last_name>
      <email>Mary.Reid@roswellpark.org</email>
    </contact>
    <contact_backup>
      <last_name>Noelle Brunsing</last_name>
      <email>Noelle.Brunsing@RoswellPark.org</email>
    </contact_backup>
    <investigator>
      <last_name>Mary Reid, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Trustees of University of Pennsylvania (Philadelphia VA Medical Center)</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anil Vachani, MD</last_name>
      <email>avachani@mail.med.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sam Solomon</last_name>
      <email>sam.solomon@pennmedicine.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Anil Vachani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anil Vachani, MD</last_name>
      <email>avachani@mail.med.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sam Solomon</last_name>
      <email>sam.solomon@pennmedicine.upenn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Anil Vachani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Veterans Research Foundation of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>14520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Atwood, MD</last_name>
      <email>atwoodcw@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Greg Owens</last_name>
      <email>Gregory.Owens@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Charles Atwood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Middle Tennessee Research Institute (Vanderbilt University)</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Massion, MD</last_name>
      <email>pierre.massion@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>Trey Helton</last_name>
      <email>John.Helton2@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Pierre Massion, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dallas VA Research Corporation</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>San Antonio Military Medical Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center Portsmouth</name>
      <address>
        <city>Portsmouth</city>
        <state>Virginia</state>
        <zip>23708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonas Carmichael, MD</last_name>
      <email>jacob.j.carmichael.mil@mail.mil</email>
    </contact>
    <contact_backup>
      <last_name>Holly LaPerriere</last_name>
      <email>holly.a.laperriere.ctr@mail.mil</email>
    </contact_backup>
    <investigator>
      <last_name>Jonas Carmichael, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Kuzniewski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 27, 2014</study_first_submitted>
  <study_first_submitted_qc>July 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>April 16, 2021</last_update_submitted>
  <last_update_submitted_qc>April 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

